Market Place
Sourcing Support
MorphoSys AG Reports Second Quarter and First Half 2022 Financial Results
03 Aug 2022 //
BUSINESSWIRE
GSK side-lines COVID drug otilimab to focus on Xevudy
28 Oct 2021 //
PHARMAPHORUM
GSK to amend Covid-19 study to confirm efficacy in older patients
25 Feb 2021 //
CLINICALTRIALSARENA
Anti-inflammatory and cancer drugs tested in UK as possible COVID-19 therapy
11 Jun 2020 //
ECONOMICTIMES
Hydroxychloroquine fails to show benefit in Covid-19 study
08 May 2020 //
CLINICALTRIALSARENA
GSK to test experimental drug to treat pneumonia from COVID-19
07 May 2020 //
REUTERS
GSK launches PhIII programme for otilimab in RA
06 Jul 2019 //
PHARMATIMES
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.